Need a specific person's email?
Browse PharmaDirections's employee directory (about 31 employees) and reveal verified emails free.
PharmaDirections's most common email format is FLast@pharmadirections.com (ex. JDoe@pharmadirections.com), used for 93% of pharmadirections.com addresses. PharmaDirections uses 3 email patterns.
| Format | Example | Share of pharmadirections.com |
|---|---|---|
| FLast@pharmadirections.comMost common | JDoe@pharmadirections.com | |
| Last@pharmadirections.com | Doe@pharmadirections.com | |
| First@pharmadirections.com | John@pharmadirections.com |
Browse PharmaDirections's employee directory (about 31 employees) and reveal verified emails free.
Pharmaceutical ManufacturingNorth Carolina, United States11-50 Employees
PharmaDirections operates as a development partner for biotech and pharmaceutical companies, guiding programs from discovery through regulatory approval to streamline the path to market. The firm uses a virtual biotech model to provide senior-level program leadership and full-spectrum drug development expertise without maintaining a large in-house team. Based in Cary, North Carolina, it emphasizes efficient, strategic planning and cost-effective execution to translate science into a regulatory pathway. Reported outcomes include managing more than $50 million in outsourced contract work, generating over 45 patents or applications for partners, and supporting more than 150 biotech collaborations. Its capabilities span preclinical and clinical strategy, CMC and formulation, regulatory and IP strategy, and comprehensive program management across small molecules, biologics, gene therapies, and drug-device combinations. In August 2025, Danforth Advisors, LLC announced the acquisition of PharmaDirections, expanding its integrated development capabilities.
Most common format
FLast@pharmadirections.com
Example: JDoe@pharmadirections.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.